Related Experiment Videos

Young women with advanced aortoiliac occlusive disease: new insights

P J Gagne1, M J Vitti, L M Fink

  • 1Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, USA.

Insights

Young women with premature aortoiliac atherosclerosis show unique hemostatic profiles, particularly elevated anticardiolipin antibodies and D-dimer levels. These findings may explain their high incidence of thromboembolic events and surgical complications.

Area of Science:

  • Vascular Medicine
  • Hematology
  • Cardiovascular Research

Background:

  • Premature atherosclerotic aortoiliac occlusive disease is rare in young women.
  • These patients often present with acute thromboembolic events.
  • Surgical interventions for this condition can be complicated by early thrombosis.

Purpose of the Study:

  • To identify distinguishing hemostatic characteristics in young women with premature atherosclerotic aortoiliac occlusive disease.
  • To investigate potential underlying hemostatic profiles contributing to their clinical presentation.
  • To compare hemostatic markers between affected young women, healthy controls, and older male patients.

Main Methods:

  • Assessed hemostatic markers including antiphospholipid antibodies, D-dimer, and coagulation factors in 24 young women with the condition.
  • Compared these markers to 21 age-matched female controls and 9 older male patients with aortoiliac occlusive disease.
  • Analyzed the incidence of thromboembolic events and surgical complications.

Main Results:

  • Elevated anticardiolipin antibodies (42%) and D-dimer levels (62.5%) were significantly observed in young female patients.
  • Thromboembolic events were common (62%) at presentation.
  • Early graft thrombosis complicated 30% of surgical reconstructions.

Conclusions:

  • A unique pattern of premature aortoiliac atherosclerosis exists in some young women.
  • Intra-arterial thromboembolic events are frequent and complicate surgical management.
  • The role of antiphospholipid antibodies in this specific patient group requires further investigation.

Related Concept Videos